HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
10.17
-0.12 (-1.17%)
At close: Jun 26, 2026, 4:00 PM EDT
10.19
+0.02 (0.20%)
After-hours: Jun 26, 2026, 4:10 PM EDT
HUTCHMED (China) Employees
HUTCHMED (China) had 1,796 employees as of December 31, 2025. The number of employees decreased by 15 or -0.83% compared to the previous year.
Employees
1,796
Change (1Y)
-15
Growth (1Y)
-0.83%
Revenue / Employee
$305,408
Profits / Employee
$254,404
Market Cap
1.82B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| Phibro Animal Health | 2,475 |
| ANI Pharmaceuticals | 970 |
| Prestige Consumer Healthcare | 890 |
| Supernus Pharmaceuticals | 778 |
| BioCryst Pharmaceuticals | 435 |
HCM News
- 3 days ago - HUTCHMED Registrational Phase 2 Trial Meets Primary Endpoint For Fanregratinib In Bile Duct Cancer - Nasdaq
- 4 days ago - Syndio Acquires Embrace.ai - Business Wire
- 11 days ago - HUTCHMED (China) Ltd (HCM) Shares Fall 3.5% -- What GF Score of 81 Tells Investors - GuruFocus
- 11 days ago - Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM) - PRNewsWire
- 12 days ago - isolved Honors Top-Performing Partners at Annual Connect for Partners Event - GlobeNewsWire
- 12 days ago - isolved Introduces New Strategic Marketplace Partners at Connect 2026, Extending People Cloud™ Capabilities for Employers and Employees - GlobeNewsWire
- 12 days ago - Paychex Recognized as a Top WorkTech Company by TIME - GlobeNewsWire
- 16 days ago - HUTCHMED's Sovleplenib Meets Phase III Goal In WAIHA, Showing 66% Durable Response Rate; Stock Up - Nasdaq